Passage Bio Stock Price on July 12, 2024

PASG Stock  USD 0.66  0.01  1.54%   
Below is the normalized historical share price chart for Passage Bio extending back to February 28, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Passage Bio stands at 0.66, as last reported on the 30th of December, with the highest price reaching 0.66 and the lowest price hitting 0.60 during the day.
IPO Date
28th of February 2020
200 Day MA
0.9182
50 Day MA
0.6628
Beta
1.196
 
Covid
If you're considering investing in Passage Stock, it is important to understand the factors that can impact its price. Passage Bio appears to be extremely dangerous, given 3 months investment horizon. Passage Bio maintains Sharpe Ratio (i.e., Efficiency) of 0.0477, which implies the firm had a 0.0477% return per unit of risk over the last 3 months. By analyzing Passage Bio's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please evaluate Passage Bio's Risk Adjusted Performance of 0.0484, semi deviation of 6.92, and Coefficient Of Variation of 2035.87 to confirm if our risk estimates are consistent with your expectations.
  
At this time, Passage Bio's Stock Based Compensation is most likely to increase significantly in the upcoming years. . At this time, Passage Bio's Price To Book Ratio is most likely to increase significantly in the upcoming years. The Passage Bio's current Price Fair Value is estimated to increase to 0.52, while Price To Operating Cash Flows Ratio is projected to decrease to (0.74). Passage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0477

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPASG
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 11.31
  actual daily
96
96% of assets are less volatile

Expected Return

 0.54
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average Passage Bio is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Passage Bio by adding it to a well-diversified portfolio.
Price Book
0.5581
Book Value
2.025
Enterprise Value
-18.4 M
Enterprise Value Ebitda
0.8725
Shares Float
45.5 M

Passage Bio Main Headline on 12th of July 2024

Filed transaction by Passage Bio Officer Chief Commercial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Passage Bio Valuation on July 12, 2024

It is possible to determine the worth of Passage Bio on a given historical date. On July 12, 2024 Passage was worth 0.93 at the beginning of the trading date compared to the closed value of 0.94. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Passage Bio stock. Still, in general, we apply an absolute valuation method to find Passage Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Passage Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Passage Bio's related companies.
 Open High Low Close Volume
  0.83    0.92    0.83    0.91    212,356  
07/12/2024
  0.93    0.94    0.88    0.94    30,902  
  0.95    0.95    0.90    0.92    69,277  
Backtest Passage Bio  |  Passage Bio History  |  Passage Bio Valuation   PreviousNext  
Open Value
0.93
0.94
Closing Value
34.85
Upside

Passage Bio Trading Date Momentum on July 12, 2024

On July 15 2024 Passage Bio was traded for  0.92  at the closing time. The top price for the day was 0.95  and the lowest listed price was  0.90 . The trading volume for the day was 69.3 K. The trading history from July 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.13% . The trading delta at closing time against the current closing price is 5.32% .

Passage Bio Fundamentals Correlations and Trends

By evaluating Passage Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Passage Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Passage financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Passage Bio Stock history

Passage Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Passage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Passage Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Passage Bio stock prices may prove useful in developing a viable investing in Passage Bio
Last ReportedProjected for Next Year
Common Stock Shares Outstanding54.7 M49.7 M
Net Loss-122.5 M-128.6 M

Passage Bio Quarterly Net Working Capital

70.27 Million

Passage Bio Stock Technical Analysis

Passage Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Passage Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Passage Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Passage Bio Period Price Range

Low
December 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Passage Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Passage Bio December 30, 2024 Market Strength

Market strength indicators help investors to evaluate how Passage Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Passage Bio shares will generate the highest return on investment. By undertsting and applying Passage Bio stock market strength indicators, traders can identify Passage Bio entry and exit signals to maximize returns

Passage Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Passage Bio's price direction in advance. Along with the technical and fundamental analysis of Passage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Passage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Passage Stock analysis

When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device